Embed Code
Cannabigerovarin (CBGV) is a #0excludeGlossary minor cannabinoid naturally present in cannabis. As a varin derivative of Cannabigerol (CBG), CBGV features a shortened #1excludeGlossary alkyl side chain, distinguishing it chemically and potentially biologically. Known as a precursor molecule, CBGV contributes to the biosynthesis of other cannabinoids like THCV and CBDV. While research on CBGV remains limited, initial findings suggest it may possess therapeutic properties, including anti-inflammatory, antimicrobial, and neuroprotective effects, positioning it as a valuable component in #3excludeGlossary cannabis products.
This article needs more reliable medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "Cannabigerovarin" – news · newspapers · books · scholar · JSTOR (March 2022) |
Cannabigerovarin (CBGV), the propyl homolog of cannabigerol (CBG), is a cannabinoid present in Cannabis. There is no observation related to the psychoactive or psychotropic effects of CBGV when consumed or inhaled.
![]() | |
![]() | |
Names | |
---|---|
IUPAC name
2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-propylbenzene-1,3-diol
| |
Other names
Cannabigerovarol
CBGV | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C19H28O2 | |
Molar mass | 288.431 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|